9 results match your criteria mir-625-3p biomarker

  • Page 1 of 1

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.

Onco Targets Ther 2021 26;14:1441-1451. Epub 2021 Feb 26.

Department of Radiology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, People's Republic of China.

Background: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality and it is urgent to find biomarkers for early detection of PDAC. Exosomal miRNAs are useful biomarkers for cancer detection. The aims of this study were to investigate the potential role of serum exosomal miRNA in detection of PDAC and to analyze the correlation between the levels of exosome miRNA and the tumor biological behaviors. Read More

View Article and Full-Text PDF
February 2021

MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.

Anticancer Res 2020 Jul;40(7):3713-3722

School of Medicine, Institute of Clinical Medicine, Clinical Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland

Background/aim: MicroRNAs (miRNAs) regulate the development of colorectal cancer (CRC). We aimed to investigate miRNAs and their relation to cancer-related signaling pathways in site-specific CRC.

Materials And Methods: We used a total of 24 left- and right-sided Finnish CRC samples (discovery cohort) and The Cancer Genome Atlas public mature miRSeq dataset of 201 CRC samples (validation cohort). Read More

View Article and Full-Text PDF

miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease.

Sci Rep 2020 02 21;10(1):3178. Epub 2020 Feb 21.

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Pulmonary disease (PD) due to nontuberculous mycobacteria (NTM) is increasing globally, but specific biomarkers for NTM-PD have not been established. As circulating miRNAs are promising biomarkers for various diseases, we investigated whether miRNAs have potential as NTM-PD biomarkers. Sera from 12 NTM-PD patients due to Mycobacterium avium, M. Read More

View Article and Full-Text PDF
February 2020

miR-625-3p promotes migration and invasion and reduces apoptosis of clear cell renal cell carcinoma.

Am J Transl Res 2019 15;11(10):6475-6486. Epub 2019 Oct 15.

Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Peking University Shenzhen Hospital, Clinical College of Anhui Medical University Shenzhen 518036, Guangdong, P. R. China.

Clear cell renal cell carcinoma (ccRCC) is a common malignancy, yet, the mechanisms underlying tumorigenesis remain unclear. Several miRNAs have been implicated in the development of RCC previously via regulation of target gene expression. As miR-625-3p has recently been identified to play a role in development of other malignancies and is reportedly upregulated in ccRCC, we sought to investigate the role of this miRNA in the progression of ccRCC. Read More

View Article and Full-Text PDF
October 2019

Identification of potential urine proteins and microRNA biomarkers for the diagnosis of pulmonary tuberculosis patients.

Emerg Microbes Infect 2018 Apr 11;7(1):63. Epub 2018 Apr 11.

The State Key Laboratory of Agricultural Microbiology, Wuhan, 430070, China.

This study identified urinary biomarkers for tuberculosis (TB) diagnosis. The urine proteomic profiles of 45 pulmonary tuberculosis patients prior to anti-TB treatment and 45 healthy controls were analyzed and compared using two-dimensional electrophoresis with matrix-assisted laser desorption/ionization time of flight mass spectrometry. Nineteen differentially expressed proteins were identified preliminarily, and western blotting and qRT-PCR were performed to confirm these changes at the translational and transcriptional levels, respectively, using samples from 122 additional pulmonary tuberculosis patients and 73 additional healthy controls. Read More

View Article and Full-Text PDF

Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis.

PLoS One 2017 22;12(9):e0185323. Epub 2017 Sep 22.

Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Objectives: Dysregulation of miRNAs and their target genes contributes to the pathophysiology of autoimmune diseases. Circulating miRNAs may serve as diagnostic/prognostic biomarkers. We aimed to investigate the association between circulating miRNAs, disease activity and spinal involvement in patients with axial spondyloarthritis (AxSpA). Read More

View Article and Full-Text PDF
October 2017

Putting a brake on stress signaling: miR-625-3p as a biomarker for choice of therapy in colorectal cancer.

Epigenomics 2016 11 25;8(11):1449-1452. Epub 2016 Oct 25.

Department of Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus, Denmark.

View Article and Full-Text PDF
November 2016

Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.

Oncotarget 2016 Sep;7(36):58606-58637

Laboratory of Experimental Pathology, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.

Background: Asbestos is a harmful and exceptionally persistent natural material. Malignant mesothelioma (MM), an asbestos-related disease, is an insidious, lethal cancer that is poorly responsive to current treatments. Minimally invasive, specific, and sensitive biomarkers providing early and effective diagnosis in high-risk patients are urgently needed. Read More

View Article and Full-Text PDF
September 2016

Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.

J Thorac Oncol 2012 Jul;7(7):1184-91

Asbestos Diseases Research Institute (ADRI), Bernie Banton Centre, University of Sydney, New South Wales, Australia.

Introduction: We investigated the ability of cell-free microRNAs (miRNAs) in plasma and serum to serve as a biomarker for malignant mesothelioma (MM).

Methods: Using miRNA microarrays, we profiled plasma samples from MM patients and healthy controls. miRNAs with significantly different abundance between cases and controls were validated in a larger series of MM patients and in an independent series of MM patients using quantitative real-time polymerase chain reaction. Read More

View Article and Full-Text PDF
  • Page 1 of 1